Speaker Details

Benjamin Kaffenberger, MD, FAAD

Benjamin Kaffenberger, MD, FAAD

SESSIONS

F072 The Morbilliform Eruption: Differentiation and Treatment of Viral, Low-risk Drug, Severe Cutaneous Adverse Reactions, and GVHD
Mar 9, 2024 • 3:30 PM - 5:30 PM • Room 6C
S055 Consultative Dermatology for the Hospitalized Patient
Mar 11, 2024 • 9:00 AM - 12:00 PM • Room 30D

HANDOUTS

Login to view handouts

DISCLOSURES

ADC Therapeutics – Consultant (1099 relationship)(Fees); Biogen – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Dermatology Foundation – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); Elsevier Inc. – Consultant(Honoraria); InflaRx – Investigator(Grants/Research Funding); Merck – Investigator(Grants/Research Funding); National Comprehensive Cancer Network – Speaker(Honoraria); National Psoriasis Foundation – Investigator(Grants/Research Funding); Novartis – Consultant(Honoraria); Novocure – Consultant(Honoraria); OnQuality Pharmaceuticals, Ltd. – Investigator(Grants/Research Funding);